DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.09) by 66.67 percent. This is a 66.67 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $75.550 million which beat the analyst consensus estimate of $72.426 million by 4.31 percent. This is a 21.33 percent decrease over sales of $96.033 million the same period last year.